Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-CarboxamidesPer Björk, Tomas Leanderson, Fredrik Ivars et al.|PLoS Biology|2009Cited by 358
S100A9 Interaction with TLR4 Promotes Tumor GrowthEva Källberg, Tomas Leanderson, David Liberg et al.|PLoS ONE|2012Cited by 138
Induction of nuclear factor‐κ<scp>B</scp> responses by the <scp>S</scp>100<scp>A</scp>9 protein is Toll‐like receptor‐4‐dependentMatteo Riva, Tomas Leanderson, Fredrik Ivars et al.|Immunology|2012Cited by 133
Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosusHelena Tydén, AA Bengtsson, Fredrik Ivars et al.|Lara D. Veeken|2013Cited by 90
Platelet‐Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus ErythematosusChristian Lood, Anders Bengtsson, Helena Tydén et al.|Arthritis & Rheumatology|2016Cited by 84